The Antacid Market Size was evaluated at USD 7.4 Billion in 2022 and is expected to reach USD 11.6 Billion by 2032 at a CAGR of 4.8%.
The antacid market presents a dynamic landscape driven by a myriad of factors, including rising incidences of digestive disorders, increasing awareness regarding gastrointestinal health, and evolving consumer preferences towards self-medication.